Patent details

Basic Information

Publication number:

EP2337779

PCT Application Number:

US2009055692

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP098121452

PCT Publication Number:

WO2010028015

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2-OXO-1,2-DIHYDRO-QUINOLINE MODULATORS OF IMMUNE FUNCTION

French Title of Invention:

MODULATEURS 2-OXO-1,2-DIHYDRO-QUINOLÉINES DE LA FONCTION IMMUNITAIRE

German Title of Invention:

2-OXO-1,2-DIHYDRO-CHINOLIN-MODULATOREN DER IMMUNFUNKTION

SPC Number:

Dates

Filing date:

02/09/2009

Grant date:

19/04/2017

EP Publication Date:

29/06/2011

PCT Publication Date:

11/03/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/04/2017

EP B1 Publication Date:

19/04/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/09/2017

Expiration date:

02/09/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/04/2017

 

 

Name:

Teva Pharmaceutical Industries Ltd.

Address:

5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)

Inventor

1

Name:

SHAHBAZ, Manouchehr M.

Address:

United States (US)

2

Name:

GANT, Thomas G.

Address:

United States (US)

Priority

Priority Number:

93943 P

Priority Date:

03/09/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/198; A61K 31/47; A61P 37/08; C07D 215/227; C07D 215/58;

Publication

European Patent Bulletin

Issue number:

201716

Publication date:

19/04/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/01/2018	Outgoing Correspondence	1